Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04832_nanopub.RAkh1QWJT2OPn6mbDM2TN5C6nvqRlR4XnLm5b4LKXdqjA#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB04832 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04832 label "Zimelidine [drugbank:DB04832]" assertion.
- drugbank:DB04832 seeAlso DB04832 assertion.
- drugbank:DB04832 identifier "drugbank:DB04832" assertion.
- drugbank:DB04832 description "Zimelidine has been banned worldwide due to serious, sometimes fatal, cases of central and/or peripheral neuropathy known as Guillain-Barré syndrome and due to a peculiar hypersensitivity reaction involving many organs including skin exanthema, flu-like symptoms, arthralgias, and sometimes eosinophilia. Additionally, zimelidine was charged to cause an increase in suicidal ideation and/or attempts among depressive patients. After its ban, it was succeeded by fluvoxamine and fluoxetine (derived from the antihistamine diphenhydramine) in that order, and the other SSRIs." assertion.
- drugbank:DB04832 title "Zimelidine" assertion.
- drugbank:DB04832 bio2rdf_vocabulary:identifier "DB04832" assertion.
- drugbank:DB04832 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04832 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04832" assertion.
- drugbank:DB04832 bio2rdf_vocabulary:x-identifiers.org DB04832 assertion.
- drugbank:DB04832 drugbank_vocabulary:drugbank-id "DB04832" assertion.
- drugbank:DB04832 drugbank_vocabulary:x-cas cas:56775-88-3 assertion.
- drugbank:DB04832 drugbank_vocabulary:x-chemspider chemspider:38293 assertion.
- drugbank:DB04832 drugbank_vocabulary:x-pubchemcompound pubchem.compound:5365247 assertion.
- drugbank:DB04832 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46504589 assertion.
- drugbank:DB04832 drugbank_vocabulary:x-atc atc:N06AB02 assertion.
- drugbank:DB04832 drugbank_vocabulary:x-wikipedia wikipedia:Zimelidine assertion.